Epidemiological and clinical characteristics of infants admitted to hospital due to human parechovirus infections: A prospective study in Spain

• Published in: Anales de Pediatría 2018-02, Vol.88 (2), p.82-88
• Main Authors: Martín Del Valle, Fernando, Calvo, Cristina, Martinez-Rienda, Inés, Cilla, Amaia, Romero, María P, Menasalvas, Ana Isabel, Reis-Iglesias, Leticia, Roda, Diana, Pena, María J, Rabella, Nuria, Portugués de la Red, María Del Mar, Megías, Gregoria, Moreno-Docón, Antonio, Otero, Almudena, Cabrerizo, María
• Format: Article
• Language: Spanish
• Subjects: Female; Hospitalization; Humans; Infant; Infant, Newborn; Male; Parechovirus; Picornaviridae Infections - diagnosis; Picornaviridae Infections - epidemiology; Picornaviridae Infections - therapy; Prospective Studies; Spain
• ISSN: 2341-2879
• DOI: 10.1016/j.anpedi.2017.02.009

Human parechovirus (HPeV) is one of the recently described picornaviridae viruses that have been associated with fever of unknown origin (FUO), clinical sepsis, gastroenteritis, meningitis, or encephalitis in very young infants. The aim of this study is to describe the epidemiology and clinical features of these viruses. A prospective multicentre 3-year study was conducted in 12 hospitals in Spain. Out of 850 specimens examined, 47 were positive (5.52%), with HPeV-3 being the most frequent (29 cases). Infections occurred throughout the year, but mainly in May and July, and a biennial distribution was observed. More than half (57%) were neonates, and only 2 children were older than 3 months. Fever was present in all children, with irritability in 45%, rash in 18.6%, and diarrhoea in 14%. The results of biochemical tests were all in normal range. The most common final diagnosis was FUO (61%), followed by clinical sepsis (29%). Up to 29% of infants were admitted to the intensive care unit, but only one patient had sequelae. Out of 850 specimens examined, 47 were positive (5.52%) for HPeV, with HPeV-3 being the most frequent (29 cases). Infections occurred throughout the year, but mainly in May and July, and a biennial distribution was observed. More than half (57%) were neonates, and only 2 children were older than 3 months. Fever was present in all children, with irritability in 45%, rash in 18.6%, and diarrhoea in 14%. The results of biochemical tests were all in normal range. The most common final diagnosis was FUO (61%), followed by clinical sepsis (29%). Up to 29% of infants were admitted to the intensive care unit, but only one patient had sequelae CONCLUSIONS: HPeV circulates in our country, mainly during spring and summer, and affects young infants with a FUO and clinical sepsis. Molecular diagnostic techniques in all hospitals could help in improving the management of patients with these infections.